Lifan Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 6
- Co-authors
- Wei Han (1 shared paper)Yangyang Wang (1 shared paper)Linhan Zhang (1 shared paper)Haohao Yin (13 shared papers)Chong-Ke Zhao (10 shared papers)Liping Sun (5 shared papers)Mengjiao Wang (1 shared paper)Yong Li (1 shared paper)
In The Last Decade
Lifan Wang
30 papers receiving 343 citations
Peers
Comparison fields: 5 of 71
- Health Informatics 8
- Cancer Research 75
- Radiology, Nuclear Medicine and Imaging 65
- Oncology 73
- Nephrology 18
Countries citing papers authored by Lifan Wang
This map shows the geographic impact of Lifan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifan Wang more than expected).
Fields of papers citing papers by Lifan Wang
This network shows the impact of papers produced by Lifan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifan Wang. The network helps show where Lifan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 61 | |
| 2 | 2019 | 61 | |
| 3 | 2021 | 44 | |
| 4 | 2020 | 27 | |
| 5 | 2021 | 22 | |
| 6 | 2021 | 16 | |
| 7 | 2023 | 13 | |
| 8 | 2014 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2017 | 3 |
About Lifan Wang
Lifan Wang is a scholar working on Epidemiology, Molecular Biology, Surgery, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 34 papers that have together received 347 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Gallbladder and Bile Duct Disorders (4 papers), MRI in cancer diagnosis (3 papers), Cutaneous Melanoma Detection and Management (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Health Informatics (8 citations), Cancer Research (75 citations), Radiology, Nuclear Medicine and Imaging (65 citations), Oncology (73 citations) and Nephrology (18 citations). Lifan Wang has collaborated with scholars based in China, Israel and Germany. Frequent co-authors include Wei Han, Yangyang Wang, Linhan Zhang, Haohao Yin, Chong-Ke Zhao, Liping Sun, Mengjiao Wang, Yong Li, Ping Li and Hui‐Xiong Xu. Their work appears in journals such as Insights into Imaging, Frontiers in Pharmacology, Medicine, Abdominal Radiology and Ultrasound in Medicine & Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.